Vicarious Surgical (RBOTW) Income from Continuing Operations (2020 - 2025)
Vicarious Surgical (RBOTW) reported Income from Continuing Operations of 11058000.0 for Q3 2025, up 35.3% year-over-year from 8172992.48 in Q3 2024, and up 16.32% quarter-over-quarter from 13215000.0 in Q2 2025.
Vicarious Surgical (RBOTW) Income from Continuing Operations (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Income from Continuing Operations data on file, last reported at 11058000.0 in Q3 2025.
- Income from Continuing Operations for Q3 2025 came in at 11058000.0, up 35.3% year-over-year; the trailing twelve-month figure through Sep 2025 was 53593000.0 (up 14.12% YoY), and the FY2024 annual result was 63223000.0, up 11.04% from the prior year.
- Income from Continuing Operations advanced to 11058000.0 in Q3 2025 per RBOTW's latest filing, from 13215000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 42527000.0 in Q1 2022 and troughed at 45124000.0 in Q3 2021.
- A 5-year average of 10737421.05 and a median of 13926000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2021 and 2022: Income from Continuing Operations plunged 24757.7% in 2021, then jumped 912.98% in 2022.
- A 5-year view of Income from Continuing Operations shows it stood at 21786000.0 in 2021, then sank by 151.32% to 11180000.0 in 2022, then decreased by 17.27% to 13111000.0 in 2023, then slipped by 6.22% to 13926000.0 in 2024, then increased by 20.59% to 11058000.0 in 2025.
- Business Quant data shows RBOTW's Income from Continuing Operations at 11058000.0 in Q3 2025, 13215000.0 in Q2 2025, and 15394000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | -13.22 Mn |
| Mar 31, 2025 | -15.39 Mn |
| Dec 31, 2024 | -13.93 Mn |
| Sep 30, 2024 | -17.09 Mn |
| Jun 30, 2024 | -15.21 Mn |
| Mar 31, 2024 | -17.00 Mn |
| Dec 31, 2023 | -13.11 Mn |
| Sep 30, 2023 | -15.70 Mn |
| Jun 30, 2023 | -15.33 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -11.18 Mn |
| Sep 30, 2022 | -24.74 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | 42.53 Mn |
| Dec 31, 2021 | 21.79 Mn |
| Sep 30, 2021 | -45.12 Mn |
| Jun 30, 2021 | -6.64 Mn |
| Mar 31, 2021 | -5.23 Mn |
| Dec 31, 2020 | -3.78 Mn |